Helping you navigate long-term care and aging with expert guidance, trusted information, and practical tools.
Explore the full range of long-term care options. From in-home support to assisted living, find straightforward guidance to make informed decisions.
Visit Learning CenterEverything you need to learn about Long-Term Care Insurance in one place. From policy types and benefits to pricing, underwriting, and more.
Visit Learning CenterExplore a range of topics centered around living your best life as you age. Discover practical advice on healthy aging strategies and planning for the future.
All News & TopicsResources and connections for businesses and partners. Access information about LTC News, advertising opportunities, partnerships, and ways to get in touch with our team.
Retatrutide is an investigational “triple-agonist” peptide being studied for obesity and metabolic disease. Researchers are examining how it affects appetite, blood sugar regulation and energy expenditure through multiple hormonal pathways. As of May 2026, Retatrutide has not received FDA approval.